[Subacute or chronic thromboembolism of the pulmonary artery. The role of fibrinolytic treatment (apropos of 9 cases)].
D000328:Adult; D000368:Aged; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D011655:Pulmonary Embolism / Q000150:complications / Q000188:drug therapy*; D011660:Pulmonary Heart Disease / Q000188:drug therapy; D013300:Streptokinase / Q000627:therapeutic use; D013997:Time Factors; D014568:Urokinase-Type Plasminogen Activator / Q000627:therapeutic use
D005343:Fibrinolytic Agents; D006493:Heparin; D013300:Streptokinase; D014568:Urokinase-Type Plasminogen Activator
Les thromboembolies subaiguës ou chroniques de l'artètre pulmonaire. La place du traitement fibrinolytique (à propos de 9 cas)